Trial of CPX-351 in Adult Patients With First Relapse Acute Myeloid Leukemia (AML)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jonathan Kolitz, MD
North Shore University Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
42 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Vancouver General Hospital/ British Columbia Cancer Agency
Vancouver, British Columbia, Canada
- Cancer Care Manitoba
Winnipeg, Manitoba, Canada
- Service Des Maladies Du Sang Chu de Lille, Hopital Claude Huriez
Lille, France
- Service Des Maladies Du Sang Hopital Haut-Leveque
Pessac, France
- Service D'Hématologie Chu Toulouse-Hôpital Purpan
Toulouse, France
- Service D'Hématologie Et Médecine Interne Chu de Nancy-Hôpital de Brabois
Vandœuvre-lès-Nancy, France
- Klinika Hematologii I Transplantologii
Gdansk, Poland
- Wojewódzki Szpital Specjalistyczny Im. M. Kopernika
Lodz, Poland
- Oddział Hematologii
Opole, Poland
- Instytut Hematologii I Transfuzjologii
Warsaw, Poland
- Akademia Medyczna We Wroclawlu
Wroclaw, Poland
- Arizona Cancer Center
Tucson, Arizona, United States
- Cedars Sinai Medical Center
Los Angeles, California, United States
- Ucla
Los Angeles, California, United States
- Uc Davis Cancer Center
Sacramento, California, United States
- University of Colorado Cancer Center
Aurora, Colorado, United States
- Northwestern University Robert H. Lurie Comprehensive Cancer Center
Chicago, Illinois, United States
- Rush University Medical Center
Chicago, Illinois, United States
- University of Chicago Medical Center Section of Hematology/oncology
Chicago, Illinois, United States
- St. Francis Cancer Center
Beech Grove, Indiana, United States
- University of Louisville Brown Cancer Center
Louisville, Kentucky, United States
- Maine General Medical Center Harold Alfond Center for Cancer Care
Waterville, Maine, United States
- Johns Hopkins University
Baltimore, Maryland, United States
- St. Louis University Medical Center
St Louis, Missouri, United States
- the Cancer Center, Hackensack University Medical Center
Hackensack, New Jersey, United States
- North Shore Lij Center for Advanced Medicine Monter Cancer Center
Lake Success, New York, United States
- New York Medical College
New York, New York, United States
- Weil Cornell Medical Center
New York, New York, United States
- Montefiore Medical Center
The Bronx, New York, United States
- Blumenthal Cancer Center/mecklenburg Medical Group
Charlotte, North Carolina, United States
- Duke Comprehensive Cancer Center
Durham, North Carolina, United States
- Jewish Hospital of Cincinatti
Cincinnati, Ohio, United States
- Oregon Health and Science University
Portland, Oregon, United States
- Oncology and Hematology at Lehigh Valley
Bethlehem, Pennsylvania, United States
- Western Pennsylvania Hospital
Pittsburgh, Pennsylvania, United States
- Utmb Comprehensive Cancer Center
Galveston, Texas, United States
- M.D. Anderson Cancer Center
Houston, Texas, United States
- Joe Arrington Cancer Center
Lubbock, Texas, United States
- Texas Tech University Health Sciences Center
Lubbock, Texas, United States
- Cancer Therapy and Research Center at the University of Tx Health Science Center
San Antonio, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Feb 2009
- Primary completion
- 31 Dec 2011
- Completion
- 31 Jan 2012
- Last update posted
- 24 Nov 2017
- Registered enrollment
- 126
- Registry id
- NCT00822094
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.